News
Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation ...
Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...
Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...
Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...
The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April ...
For decades, non-small cell lung cancer (NSCLC) stood as one of the formidable challenges in oncology, often diagnosed late and treated with limited options. But now, it looks like the therapeutic ...
With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...
The U.S. National Institutes of Health (NIH) – the primary federal agency for biomedical research – slashed nearly 800 projects and vowed to wipe out billions of dollars from biomedical research ...
How do TLR agonists work? Toll-like receptors (TLRs) are a family of proteins that play an integral part in the immune system, as they are the first line of defense against pathogens and harmful cells ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results